MR-visible brain water content in human acute stroke

Prior research has shown that water content in brain tissue is a critical factor in interpreting 1H-MRS data. However, the assumption that water content remains stable in diseased tissue has not been thoroughly tested in stroke patients. This gap motivated researchers to investigate how water content changes over time in ischemic brain regions. It was already known that cerebral infarction leads to complex physiological changes, including edema and altered blood flow. No prior work had resolved whether these changes affect water content in a measurable way. This uncertainty drove the need for a longitudinal study using 1H-MRS to track water content in stroke patients. The study aimed to clarify whether water content remains a reliable internal standard across different stages of stroke. Establishing this would help improve the accuracy of metabolite quantification in clinical settings. The research also sought to understand how these findings relate to cerebral blood flow changes over time.

The study aimed to evaluate the stability of brain water content in acute stroke patients using 1H-MRS. Researchers focused on whether water content remains constant in ischemic tissue over time. The motivation arose from the need to validate the use of water as an internal standard in quantitative 1H-MRS. This is particularly important in stroke patients where tissue changes are dynamic. The specific problem addressed was the potential variability in water content during different phases of infarction. By measuring water content serially, the study aimed to determine if this parameter is reliable for metabolite quantification. The research also sought to correlate these findings with cerebral blood flow measurements. Understanding this relationship could improve the interpretation of 1H-MRS data in stroke diagnostics.

Researchers used 1H-MRS to estimate brain water content in patients with acute cerebral infarction. Measurements were conducted in the acute, subacute, and chronic phases of stroke. Fourteen patients were included, along with nine healthy controls for comparison. To assess cerebral blood flow, SPECT-scanning with 99mTc-HMPAO was performed in the patients. Water content was measured at four time intervals: 0–3, 4–7, 8–21, and >180 days post-stroke. The same time intervals were used for rCBF measurements. Data were analyzed to identify trends in water content and blood flow over time. The study design allowed for a longitudinal assessment of both parameters in the same patients.

Water content in the infarct area was 37.7 mol/kg at 0–3 days post-stroke. It increased to 41.8 mol/kg at 4–7 days, then decreased to 35.2 mol/kg at 8–21 days. At >180 days, water content was 39.3 mol/kg. The increase between Day 0–3 and Day 4–7 was statistically significant (p = 0.034). A decrease from Day 0–3 to Day 8–21 was also significant (p = 0.028). Water content at Day 4–7 was higher than in controls (p ≤ 0.05). Mean rCBF was 76% at 0–3 days, rising to 94% at 4–7 days. It increased further to 106% at 8–21 days, then dropped to 64% at >180 days. The rCBF increase from Day 0–3 to Day 4–7 was significant (p = 0.050). No correlation was found between rCBF and water content.

The study found that water content in ischemic brain tissue increases significantly between Day 4–7 after stroke. This finding suggests that water may not be a stable internal standard for 1H-MRS in this time frame. The authors propose that this variability should be considered when interpreting quantitative 1H-MRS data in stroke patients. The increase in water content was not correlated with changes in rCBF. The results highlight the dynamic nature of brain tissue in the acute phase of infarction. The findings support the need for caution when using water as a reference in metabolite quantification. The study provides evidence that water content fluctuates during stroke recovery. These results may influence future approaches to 1H-MRS in clinical stroke research.